Journals / Cukurova Medical Journal / 2021 / Cilt: 46 - Sayı: 1

A novel non-invasive prenatal test technique with genosensor

Genosensör ile yeni bir girişimsel olmayan doğum öncesi tanı yöntemi

Pages
208–215
Publication Date
2021-03-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compared with the traditional methods used in routine, it was found to be more cost-effective, faster, with high specificity and detection efficiency.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study is to develop a new procedure with nanopolymer based genosensor for the determination of paternal mutation from cell-free fetal DNA in maternal blood.
📊
Key Findings & Data:Materials and Methods: β-thalassemia IVS1-110 mutation analysis was performed using quartz-crystal microbalance (QCM) and biosensor technologies.
💡
Conclusion & Impact:Compared with the traditional methods used in routine, it was found to be more cost-effective, faster, with high specificity and detection efficiency.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Genosensor · Cell-FreeFetal DNA · Nanopolymer

Abstract

Purpose: The aim of this study is to develop a new procedure with nanopolymer based genosensor for the determination of paternal mutation from cell-free fetal DNA in maternal blood. Materials and Methods: β-thalassemia IVS1-110 mutation analysis was performed using quartz-crystal microbalance (QCM) and biosensor technologies. For this purpose, the probes of the mutation were immobilized on the genosensor electrode surface by means of Poly Hema-MAC nanopolymer and then samples were added to the working cell for detection. Optimization, characterization, sensitivity and specificity studies of the genosensor were performed. Results: Biosensor measurements were obtained between -0.6 and 0.8 V in a constant current range by cyclic voltammetry. Common results were obtained with ARMS method in fetuses who had non-invasive prenatal diagnosis tests. When the ARMS results were compared with the genosensor results statistically, a 99% concordance rate was obtained in the ROC curve drawn. Conclusions: The developed biosensor can detect the presence of paternal mutation of the fetüs specific to the probe on its surface. Compared with the traditional methods used in routine, it was found to be more cost-effective, faster, with high specificity and detection efficiency.

Özet

Amaç: Bu çalışmanın amacı, maternal kandaki “cell-free” fetal DNA'dan paternal mutasyon tayini için nanopolimer bazlı genosensör ile yeni bir prosedür geliştirmektir. Gereç ve Yöntem: Kuvars-kristal mikrobalans (QCM) ve biyosensör teknolojilerini kullanılarak β-talasemi IVS1-110 mutasyonun analizine uygulanmıştır. Bu amaçla, mutasyona ait problar genosensör elektrodu üzerine PoliHema-MAC nanopolimeri aracılığıyla bağlandı ve daha sonra örnekler tespit amacıyla çalışma hücresine eklendi. Genosensörün optimizasyon, karakterizasyon, duyarlılık ve özgüllük çalışmaları yapıldı. Bulgular: Biyosensör ölçümleri -0,6 - 0,8 V sabit akım aralığında döngüsel volatmetriyle elde edildi. Girişimsel olmayan doğum öncesi tanı testi yapılan fetüslerde ARMS yöntemiyle ortak sonuçlar elde edilmiştir. ARMS sonuçları genosensör sonuçları ile istatistiksel olarak karşılaştırıldığında çizilen ROC eğrisinde %99 uyumluluk oranı elde edilmiştir. Sonuç: Geliştirilen biyosensör, yüzeyinde bulunan proba özgül olarak, fetüsün paternal mutasyonunun varlığını ortaya koyabilmektedir. Rutinde kullanılan geleneksel yöntemlerle karşılaştırıldığında, daha düşük maliyetli, hızlı sonuç verebilen, özgüllüğü ve saptama etkinliği yüksek olarak bulunmuştur.

🔖

Cite This Article

KÖKBAŞ, U., KAYRIN, L., TULİ, A. (2021). A novel non-invasive prenatal test technique with genosensor. Cukurova Medical Journal, Cilt: 46 - Sayı: 1, 208–215. https://ajindex.com/articles/115466

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Beattie KL, Beattie WG, Meng L, Turner SL, CoralVazquez R, Smith DD et al. Advances in genosensor research. Clin Chem. 1995;41:700-6
  2. Sabahi A, Salahandish R, Ghaffarinejad A, Omidinia E. Electrochemical nano-genosensor for highly sensitive detection of miR-21 biomarker based on SWCNT-grafted dendritic Au nanostructure for early detection of prostate cancer. Talanta. 2020;209:120595
  3. Daneshpour M, Moradi LS, Izadi P, Omidfar K. Femtomolar level detection of RASSF1A tumor suppressor gene methylation by electrochemical nanogenosensor based on Fe3O4/TMC/Au nanocomposite and PT-modified electrode. Biosens Bioelectron. 2016;77:1095-1103
  4. Kokbas U, Kayrin L, Tuli A. Lab-on-a-chip based biosensor for the real-time multiplex analysis of alpha thalassemia mutations from cell-free DNA. Febs Open Bio. 2019;9:374
  5. Semsi R, Kokbas U, Arslan B, Dincel AS, Ergunol E, Kayrin L. Comparison of chemiluminescence immunoassay and biosensor methods for measurement of saliva glucose levels in adults. Febs Open Bio. 2019;9:129
  6. Fernandes AM, Abdalhai MH, Ji J, Xi BW, Xie J, Sun J et al. Development of highly sensitive electrochemical genosensor based on multiwalled carbon nanotubes-chitosan-bismuth and lead sulfide nanoparticles for the detection of pathogenic Aeromonas. Biosens Bioelectron. 2015;63:399-406
  7. Malecka K, Swieton E, Verwilst P, Stachyra A, Sirko A, Dehaen W et al. Ultrasensitive electrochemical genosensor for direct detection of specific RNA sequences derived from avian influenza viruses present in biological samples. Acta Biochim Pol. 2019;66:299-304
  8. Kanwal S, Bukhari S, Perveen S. Molecular genetics and prenatal diagnosis of beta thalassemia to control transfusion dependent births in carrier Pakistani couples. J Pak Med Assoc. 2017;67:1030-4
  9. Fortunati S, Rozzi A, Curti F, Giannetto M, Corradini R, Careri M. Novel amperometric genosensor based on peptide nucleic acid (PNA) probes immobilized on carbon nanotubes-screen printed electrodes for the determination of trace levels of non-amplified DNA in genetically modified (GM) soy. Biosens Bioelectron. 2019;129:7-14
  10. Yenilmez ED, Kokbas U, Kartlasmis K, Kayrin L, Tuli A. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. Plos One. 2018;13: e0197855
  11. Fries N, Le Garrec S, Egloff M, Sault C, Dreux S, Mangione R et al. Non-invasive prenatal testing: what are we missing? Ultrasound Obstet Gynecol. 2020
  12. Park AL, Huang